概要：BxPC-3 cells were derived in 1986 from the pancreatic adenocarcinoma of a 61-year-old female patient who underwent radiation and chemotherapy and has since proven to be tumorigenic, making them ideal for investigating cancer growth and progression.
Notably, no evidence of metastasis was observed, making BxPC-3 cells relevant for studying primary tumor behavior and response to treatments.
Tumors grown from BxPC-3 cells in nude mice closely resemble the primary tumor from which they were derived, producing carcinoembryonic antigen, human pancreas cancer-associated antigen, human pancreas-specific antigen, and traces of mucin, which is crucial for studying pancreatic adenocarcinomas characterized by the presence of mucinous tissues.
Furthermore, these cells lack the KRAS mutation commonly found in pancreatic tumors.
In addition, BxPC-3 cells do not contain the SMAD4/DPC4 protein due to homozygous deletions.
These genetic features differentiate BxPC-3 cells from some other pancreatic cancer cell lines.
While it may not represent the majority of pancreatic cancers, it offers a unique perspective for specific research inquiries.
The angiogenic factors interleukin-8 (IL-8), vascular endothelial growth factor (VEGF), and prostaglandin E2 (PGE2) are significantly expressed in BxPC-3 cells.
This feature presents an exciting opportunity for researchers to explore potential therapeutic targets in angiogenesis, a critical process involved in cancer growth and metastasis.
